Vanguard is known primarily for two dividend ETFs, but it has others that deserve equal consideration.
on 84 share classes of 53 mutual funds and exchange-traded funds. The lower expense ratios take effect Feb. 2, 2026. These funds represented about 10% of the $11.5 trillion in Vanguard’s US mutual ...
Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index return. FDA drug approvals often trigger 20% to 50% single-day stock jumps that LABU’s ...
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...
Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results